HomeInsightsMarket Capitalization

Market Capitalization of Glenmark Pharmaceuticals Ltd

Market Capitalization of Glenmark Pharmaceuticals Ltd

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Market Cap

₹ 41765.26 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Glenmark Pharmaceuticals Ltd is ₹ 41765 crore as of 22 Nov 24 .
  • The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 18215 crore on March 2019 to ₹ 27019 crore on March 2024 . This represents a CAGR of 6.79% over 6 years.
  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1480 as of 22 Nov 15:30 .
  • The dividend payouts of Glenmark Pharmaceuticals Ltd changed from ₹ 2 to ₹ 2.5 over 6 quarters. This represents a CAGR of 16.04% .

Historical Market Cap of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Glenmark Pharmaceuticals Ltd

No data available

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Share Price

₹ 1480.05

14.75 (1.01%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241480.05
21 Nov 20241465.3
19 Nov 20241492.35
18 Nov 20241483.5
14 Nov 20241531.7
13 Nov 20241538.5
12 Nov 20241577.25
11 Nov 20241634.7
08 Nov 20241665.5
07 Nov 20241657.7

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Glenmark Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Glenmark Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Glenmark Pharmaceuticals Ltd

No data available

* All values are in

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.
  • The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Ltd eases for fifth straight session

Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...

Read more

18 Nov 202413:35

News

Glenmark Pharma reports turnaround Q2 results

Revenue from operations increased 2.29% year on year (YoY) to Rs 3,133.79 crore in the qua...

Read more

15 Nov 202414:40

News

Glenmark Pharmaceuticals Ltd gains for third straight session

Glenmark Pharmaceuticals Ltd gained for a third straight session today. The stock is quoti...

Read more

06 Nov 202413:05

News

Glenmark Pharmaceuticals declare Quarterly Result

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...

Read more

31 Oct 202412:07

News

Glenmark Pharmaceuticals Ltd spurts 2.21%

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

08 Oct 202413:05

News

Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US ...

Read more

23 Sep 202410:12

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Glenmark Pharmaceuticals Ltd Market Cap

What is the market cap of Glenmark Pharmaceuticals Ltd?

As of November 23, 2024, Glenmark Pharmaceuticals Ltd has a market capitalization of ₹41765.26, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Glenmark Pharmaceuticals Ltd's market capitalization?

Glenmark Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Glenmark Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Glenmark Pharmaceuticals Ltd's market capitalization change?

Glenmark Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*